A diffusion tensor imaging and neurocognitive study of HIV-positive children who are HAART-naïve "slow progressors"

Jacqueline Hoare1, Jean-Paul Fouche, Bruce Spottiswoode

  • 1Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa. hoare.jax@googlemail.com

Insights

Children with slow-progressing HIV infection show significant cognitive deficits and brain changes. Demyelination in key brain areas like the corpus callosum may explain these neurodevelopmental issues.

Area of Science:

  • Neuroscience
  • Pediatrics
  • Infectious Diseases

Background:

  • Few studies examine neurocognitive outcomes in children with slow-progressing HIV.
  • Slow progressors are vertically infected children with minimal antiretroviral therapy.

Purpose of the Study:

  • To compare neuropsychological and neuroimaging findings in asymptomatic, slow-progressing HIV-positive children versus controls.
  • To investigate brain structural changes, particularly in white matter tracts, associated with slow HIV progression.

Main Methods:

  • Compared 12 asymptomatic HIV-positive children (8-12 years) with matched controls.
  • Utilized a neuropsychological battery and diffusion tensor imaging (DTI).
  • Focused DTI analysis on the corpus callosum, internal capsule, and superior longitudinal fasciculus.

Main Results:

  • HIV-positive children performed worse on IQ, visuospatial processing, visual memory, and executive functioning tests.
  • Observed lower fractional anisotropy (FA) and higher mean diffusivity (MD) and radial diffusivity (RD) in the corpus callosum of slow progressors.
  • Found increased MD in the superior longitudinal fasciculus and correlations between cognitive deficits and white matter integrity.

Conclusions:

  • Slow-progressing pediatric HIV infection is associated with significant cognitive impairment.
  • Neuroimaging reveals white matter abnormalities, suggesting demyelination as a key pathological process.
  • Findings highlight the need for monitoring and intervention in this vulnerable pediatric population.